Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 3
1951 4
1952 3
1953 8
1954 3
1955 5
1956 3
1957 3
1958 2
1959 4
1960 7
1962 3
1963 2
1964 3
1965 1
1967 3
1968 3
1969 6
1970 5
1971 3
1972 2
1973 2
1974 2
1975 10
1976 3
1977 6
1978 2
1979 5
1983 2
1990 2
1993 1
1994 1
1995 2
1996 1
1997 1
1999 3
2001 3
2002 3
2003 2
2004 5
2005 4
2006 3
2007 4
2008 5
2009 4
2010 8
2011 4
2012 7
2013 8
2014 14
2015 6
2016 8
2017 12
2018 13
2019 11
2020 12
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

237 results
Results by year
Filters applied: . Clear all
Page 1
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines.
Alexandre J, Cautela J, Ederhy S, Damaj GL, Salem JE, Barlesi F, Farnault L, Charbonnier A, Mirabel M, Champiat S, Cohen-Solal A, Cohen A, Dolladille C, Thuny F. Alexandre J, et al. Among authors: charbonnier a. J Am Heart Assoc. 2020 Sep 15;9(18):e018403. doi: 10.1161/JAHA.120.018403. Epub 2020 Sep 5. J Am Heart Assoc. 2020. PMID: 32893704 Free PMC article.
Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia.
Etienne G, Guilhot J, Rea D, Rigal-Huguet F, Nicolini F, Charbonnier A, Guerci-Bresler A, Legros L, Varet B, Gardembas M, Dubruille V, Tulliez M, Noel MP, Ianotto JC, Villemagne B, Carré M, Guilhot F, Rousselot P, Mahon FX. Etienne G, et al. Among authors: charbonnier a. J Clin Oncol. 2017 Jan 20;35(3):298-305. doi: 10.1200/JCO.2016.68.2914. Epub 2016 Oct 31. J Clin Oncol. 2017. PMID: 28095277
Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study.
Rea D, Nicolini FE, Tulliez M, Guilhot F, Guilhot J, Guerci-Bresler A, Gardembas M, Coiteux V, Guillerm G, Legros L, Etienne G, Pignon JM, Villemagne B, Escoffre-Barbe M, Ianotto JC, Charbonnier A, Johnson-Ansah H, Noel MP, Rousselot P, Mahon FX; France Intergroupe des Leucémies Myéloïdes Chroniques. Rea D, et al. Among authors: charbonnier a. Blood. 2017 Feb 16;129(7):846-854. doi: 10.1182/blood-2016-09-742205. Epub 2016 Dec 8. Blood. 2017. PMID: 27932374 Free article.
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients.
Pagliardini T, Castagna L, Harbi S, Porta MD, Rey J, Fürst S, Bramanti S, Saillard C, Legrand F, Maisano V, Faucher C, Granata A, Hospital MA, Lining W, Weiller PJ, Calmels B, Charbonnier A, Lemarie C, Chabannon C, Vey N, Mokart D, Blaise D, Devillier R. Pagliardini T, et al. Among authors: charbonnier a. Biol Blood Marrow Transplant. 2019 Sep;25(9):1803-1809. doi: 10.1016/j.bbmt.2019.05.014. Epub 2019 May 22. Biol Blood Marrow Transplant. 2019. PMID: 31128325 Free article. Clinical Trial.
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial.
Mahon FX, Réa D, Guilhot J, Guilhot F, Huguet F, Nicolini F, Legros L, Charbonnier A, Guerci A, Varet B, Etienne G, Reiffers J, Rousselot P; Intergroupe Français des Leucémies Myéloïdes Chroniques. Mahon FX, et al. Among authors: charbonnier a. Lancet Oncol. 2010 Nov;11(11):1029-35. doi: 10.1016/S1470-2045(10)70233-3. Epub 2010 Oct 19. Lancet Oncol. 2010. PMID: 20965785 Clinical Trial.
Iatrogenic cutaneous graft versus host disease.
Cohen-Sors R, Arnault JP, Attencourt C, Charbonnier A, Adas A, Chaby G, Lok C. Cohen-Sors R, et al. Among authors: charbonnier a. Dermatol Online J. 2020 Nov 15;26(11):13030/qt16z1159r. Dermatol Online J. 2020. PMID: 33342180 Free article.
Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study.
Bossard JB, Beuscart JB, Robin M, Mohty M, Barraco F, Chevallier P, Marchand T, Rubio MT, Charbonnier A, Blaise D, Bay JO, Botella-Garcia C, Damaj G, Beckerich F, Ceballos P, Cluzeau T, Cornillon J, Meunier M, Orvain C, Duhamel A, Garnier F, Kiladjian JJ, Yakoub-Agha I; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC), the France-Intergroupe des Syndromes Myéloprolifératifs (FIM) and the Agence de la BioMédecine (ABM). Bossard JB, et al. Among authors: charbonnier a. Am J Hematol. 2021 Jan;96(1):80-88. doi: 10.1002/ajh.26034. Epub 2020 Nov 18. Am J Hematol. 2021. PMID: 33108024 Clinical Trial.
237 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page